Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shah

Showing results (231-240 of 296) with videos related to

Pageof 30
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2024
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse EventsSarah E Fayle, Nicolas L Palaskas, Bilal A Siddiqui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2019
Design Strategies for Biocontainment Units to Reduce Risk During Doffing of High-level Personal Protective EquipmentMaria F Wong, Zorana Matić, Gabrielle C Campiglia, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 13, 2025
Biodistribution of Macroaggregated Albumin (MAA) After Tumor Model Development and Characterization in a Porcine Lung Cancer ModelMatthew M Niemeyer, Yifan Wang, Maximillian J Carlino, et al.
The Lancet. Oncology|October 31, 2021
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trialChad Tang, Pavlos Msaouel, Kieko Hara, et al.
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
Bone Marrow Transplantation|April 9, 2014
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cellsX Liu, S N Robinson, T Setoyama, et al.
Frontiers in Immunology|October 20, 2022
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysisMuhammad Umair Mushtaq, Moazzam Shahzad, Amna Y Shah, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTENDAlexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
The Oncologist|November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint TherapyAndrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
Applied Optics|May 14, 2015
Development and application of spherically curved charge-coupled device imagersJ A Gregory, A M Smith, E C Pearce, et al.
Pageof 30

Showing results (231-240 of 296) with videos related to

Sort By:
Pageof 30
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2024
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse EventsSarah E Fayle, Nicolas L Palaskas, Bilal A Siddiqui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2019
Design Strategies for Biocontainment Units to Reduce Risk During Doffing of High-level Personal Protective EquipmentMaria F Wong, Zorana Matić, Gabrielle C Campiglia, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 13, 2025
Biodistribution of Macroaggregated Albumin (MAA) After Tumor Model Development and Characterization in a Porcine Lung Cancer ModelMatthew M Niemeyer, Yifan Wang, Maximillian J Carlino, et al.
The Lancet. Oncology|October 31, 2021
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trialChad Tang, Pavlos Msaouel, Kieko Hara, et al.
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
Bone Marrow Transplantation|April 9, 2014
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cellsX Liu, S N Robinson, T Setoyama, et al.
Frontiers in Immunology|October 20, 2022
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysisMuhammad Umair Mushtaq, Moazzam Shahzad, Amna Y Shah, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTENDAlexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
The Oncologist|November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint TherapyAndrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
Applied Optics|May 14, 2015
Development and application of spherically curved charge-coupled device imagersJ A Gregory, A M Smith, E C Pearce, et al.
Pageof 30